Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Kisqali Femara Co-Pack
Ribociclib and letrozole combination is used in pre/perimenopausal or postmenopausal women to treat hormone receptor (HR)-positive, HER-2 negative advanced or metastatic (cancer that has spread) breast cancer.
Ribociclib belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor.
Female hormones that occur naturally in the body can increase the growth of some breast cancers. Letrozole works by decreasing the amounts of these hormones in the body.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: